Entyvio 108 MG/0.68 1S
Ended Awarded
- Contract number
- SPE2DR26FARCD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,912
Award facts
- Contract value 100% obligated
- $25,912.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,912.20 to AmerisourceBergen Drug Corp for the supply of Entyvio 108 mg/0.68 mL on October 30, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by October 31, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. Entyvio is a biologic medication primarily used to treat inflammatory bowel diseases, including ulcerative colitis and Crohn's disease, reflecting the federal government's ongoing need for specialized pharmaceutical products to support military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp leverages this comprehensive contract vehicle to supply a broad portfolio of medications and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The company's consistent success in competing for DLA orders demonstrates its established capability to meet federal pharmaceutical procurement requirements and support the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26FARCD?
SPE2DR26FARCD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DR26FARCD worth?
The government has obligated $25,912 on SPE2DR26FARCD.
Is contract SPE2DR26FARCD an order under another contract?
Yes. SPE2DR26FARCD is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FARCD competed?
The extent of competition for SPE2DR26FARCD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award